Pharmaceuticals Market Reports

Kalorama Information is your trusted source for market research on the pharmaceutical industry. Reports provide key trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with pharmaceutical industry leaders to provide accurate market assessments while personally researching the market to offer keen insights into consumer and institutional trends.

<< prev 1 2 3 4 5 6 7 8 9 10 next >>

Title	Published	Price
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease.  |  more... Search inside this report	May 11, 2012	$3,995.00
Out-of-Pocket Healthcare 2012 Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies.  The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates.  While insurance is the most common  |  more... Search inside this report	Apr 3, 2012	$995.00
The Market for Home Care Products, 7th Edition This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living.  Growth in the ambulatory aids market continues to be driven by several key trends including the aging U.S. population, new product introductions and relatively generous  |  more... Search inside this report	Apr 6, 2012	$3,995.00
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape the market for treatments in the future. It  |  more... Search inside this report	Mar 1, 2012	$3,995.00
Point of Care Diagnostics Bundle (POC Diagnostic Markets, POC Diagnostics for Emerging Infectious Diseases, POC Dx in Physician Office Labs) Point of Care Diagnostics represents one of the highest-growth industries in testing. This bundle allows Kalorama Information customers to save by purchasing one PDF which contains our most popular previously published reports on point-of-care testing. POINT OF CARE DIAGNOSTICS MARKETS Published in 2010,  |  more... Search inside this report	Mar 2, 2012	$3,995.00
The World Anesthesia Drug Market (General, Local, Adjunctive) This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia  |  more... Search inside this report	Mar 22, 2012	$3,995.00
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others) Antivirals (Nucleoside  |  more... Search inside this report	Feb 1, 2012	$3,800.00
White Paper: Bariatric Surgery Trends The popular of gastric bypass, or bariatric surgery in the United States is increasing. This White Paper from Kalorama provides information on the trends of Bariatric Surgery procedures in the United States for Women and for Men, and describes the surgeries. The White Paper  |  more... Search inside this report	Dec 19, 2011	$0.00
Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts) Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? How  |  more... Search inside this report	Feb 1, 2012	$2,500.00
Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases) There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists  |  more... Search inside this report	Jan 1, 2012	$3,995.00
Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process.  |  more... Search inside this report	Jan 1, 2012	$3,995.00
US Pharmaceutical, Medical Device, Diagnostics Markets Kalorama Information reports on a wide range of topics related to healthcare industry markets in the United States. This report, The Kalorama U.S.Pharmaceutical, Medical Device, Diagnostics Markets provides a broad look at the healthcare system and a summary of the market for the healthcare industry in the United States.  |  more... Search inside this report	Dec 1, 2011	$500.00
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including:  |  more... Search inside this report	Jan 1, 2012	$3,500.00
World Market for Gastrointestinal Devices (Rigid, Flexible and Capsule Endoscopes, Bariatric Surgery, Ostomy Products, Enteral Feeding Pumps and Other Devices) This report, The World Market for Gastrointestinal Devices , details the market for endoscopes and other devices used for treating gastrointestinal conditions. There are many factors behind the growth of this market. Cancer is one of leading reasons for surgery with more than 1 million new cases of  |  more...	Jan 1, 2012	$3,500.00
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known  |  more... Search inside this report	Jul 1, 2011	$3,995.00
Vaccines 2011-15: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and  |  more... Search inside this report	Jul 1, 2011	$3,600.00
Point of Care Diagnostics for Emerging Infectious Disease Threats (Dengue Fever, HIV, HPV, STDs, Chagas, TB, and Other IDs): Market Analysis and Technical Considerations The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of  |  more... Search inside this report	Oct 1, 2011	$2,995.00
White Paper - HAI Treatments: A Challenging Market Given the attention focused on hospital-acquired infections (HAIs), one would think there would be a thriving market for pharmaceutical products to combat this scourge. And there is a fairly large-sized market - over $8.06 billion earned in 2010 by companies selling pharmaceutical treatments. But it is a market that has  |  more... Search inside this report	Aug 25, 2011	$0.00
China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets (Market Size Estimates, Regional Healthcare Market Breakouts, Demographics and Regulation) China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a  |  more... Search inside this report	Oct 15, 2011	$2,500.00
Mabs vs. TKIs: Two Paths to Cancer Targeting -White Paper Monoclonal antibodies (mAbs) Tyrosine kinase inhibitors (TKIs) represent two types of cancer treatment. Both involve biological processes but attack the problem in different ways. One limits the bodies cell growth, the other helps the immune system target cancer cells. From a market perspective  |  more... Search inside this report	Nov 1, 2011	$0.00
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in  |  more... Search inside this report	Oct 15, 2011	$3,500.00
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies will be a  |  more... Search inside this report	Jul 1, 2011	$2,995.00
The World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants) Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid arthritis, which is an autoimmune disease. Successful treatment of arthritis has resulted from a growing  |  more... Search inside this report	Nov 1, 2011	$3,500.00
European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of Europe The European vaccines market has demonstrated growth even through tough economic times. This has mainly been due to the introduction of vaccines in untapped disease markets and government’s acceptance and willingness to pay for new products. This has encouraged market participants to increase spending in research and development.  |  more... Search inside this report	Nov 1, 2010	$995.00
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail.  |  more... Search inside this report	Jun 1, 2010	$3,995.00
Title	Published	Price

<< prev 1 2 3 4 5 6 7 8 9 10 next >>